Livzon Pharmaceutical Group Inc. provided earnings guidance for the period from January 01, 2018 to June 30, 2018. For the period the company estimated net profit attributable to the shareholders of the listed company approximately RMB 604.8030 million - RMB 655.2033 million. Net profit attributable to the shareholders of the listed company after deducting the extraordinary gain or loss is approximately RMB 546.3210 million - RMB 591.8477 million­. Basic earnings per share is approximately RMB 0.84 - RMB 0.92 per share.